Bio-Thera, Hikma Pharmaceuticals sign $150m licensing deal for BAT2206

Chinese biopharma company Bio-Thera Solutions has signed a commercialization and license deal worth up to $150 million with Hikma Pharmaceuticals to commercialize the former’s BAT2206. ... Read More